Nursing Perspectives on the Use of Continuous Glucose Monitoring in the Intensive Care Unit

J Diabetes Sci Technol. 2023 May;17(3):649-655. doi: 10.1177/19322968231170616. Epub 2023 Apr 20.

Abstract

Background: The COVID-19 pandemic necessitated rapid implementation of continuous glucose monitoring (CGM) in the intensive care unit (ICU). Although rarely reported, perceptions from nursing staff who used the systems are critical for successful implementation and future expanded use of CGM in the inpatient setting.

Methods: A 22-item survey focused on CGM use was distributed to ICU nurses at two large academic medical centers in the United States in 2022. Both institutions initiated inpatient CGM in the spring of 2020 using the same CGM+point of care (POC) hybrid protocol. The survey employed a 1- to 5-point Likert scale regarding CGM sensor insertion, accuracy, acceptability, usability, training, and perceptions on workload.

Results: Of the 71 surveys completed, 68 (96%) nurses reported they cared for an ICU patient on CGM and 53% reported they had independently performed CGM sensor insertion. The ICU nurses overwhelmingly reported that CGM was accurate, reduced their workload, provided safer patient care, and was preferred over POC glucose testing alone. Interestingly, nearly half of nurses (49%) reported that they considered trend arrows in dosing decisions although trends were not included in the CGM+POC hybrid protocol. Nurses received training through multiple modalities, with the majority (80%) of nurses reporting that CGM training was sufficient and prepared them for its use.

Conclusion: These results confirm nursing acceptance and preference for CGM use within a hybrid glucose monitoring protocol in the ICU setting. These data lay a blueprint for successful implementation and training strategies for future widespread use.

Keywords: continuous glucose monitoring (CGM); critical care; hospital; implementation; nursing; training.

MeSH terms

  • Blood Glucose
  • Blood Glucose Self-Monitoring* / methods
  • COVID-19*
  • Humans
  • Intensive Care Units
  • Pandemics

Substances

  • Blood Glucose